Pharynx Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pharynx Cancer trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 49 trials

RecruitingPhase 2

NCT06029270

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta…

This phase II trial tests the addition of BMS-986016 (relatlimab) to the usual immunotherapy after initial treatment for nasopharyngeal cancer that has come bac…

United States156 participantsStarted 2024-07-15

Treatment: Biospecimen Collection, Bone Scan

RecruitingNot Applicable

NCT04425265

Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized…

This study aims at exploring whether plasma radiofrequency ablation at low temperature is associated with better survival outcome in localized recurrent nasopha…

China500 participantsStarted 2020-06-30

Treatment: Plasma radiofrequency ablation, Electrocautery block resection

RecruitingPhase 2

NCT05136196

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S…

This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamou…

United States150 participantsStarted 2022-12-06

Treatment: Biopsy Procedure, Biospecimen Collection

RecruitingNot Applicable

NCT06915454

High-Resolution PET-CT Imaging for Surgical Margin Visualization

Imaging will be exploratory and be used intraoperatively. There have been no discovered risks associated with the device to be used in this study, and none are…

United States50 participantsStarted 2025-09-03

Treatment: Intra-op PET/CT Specimen Scanner

RecruitingEarly Phase 1

NCT06819228

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

This study is exploring the use of Panitumumab in Head and Neck Cancer. Panitumumab is an approved drug named Vectibix and is used as an anti-cancer agent in ot…

United States18 participantsStarted 2025-04-17

Treatment: Panitumumab IRDye 800

RecruitingPhase 2

NCT06445114

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

This is a single institution phase II study that will enroll patients with T0-3N0-2 p16-positive oropharyngeal squamous cell carcinoma (OSCC) undergoing resecti…

United States50 participantsStarted 2025-05-12

Treatment: Cisplatin

All recent trials (100 shown)

Active — Not RecruitingPhase 2/3

NCT06295731

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

This seamless phase 2/3 randomized controlled study will evaluate the efficacy and safety of the hexavalent OX40 agonist antibody INBRX-106 combined with the an…

United States410 participantsStarted 2024-05-14

Treatment: INBRX-106, Pembrolizumab

Not Yet RecruitingNot Applicable

NCT07552545

Full-wrap Versus Conventional Suspension for Reducing Soft Palate Injury Rate

This study aims to evaluate whether the use of full-wrap suspension, compared with the traditional double-strap suspension, can effectively reduce the risk of i…

China138 participantsStarted 2026-04-30

Treatment: Intraoperative soft palate suspension using the double-strap method., Intraoperative soft palate suspension using the full-wrap method.

Pharynx Cancer

Trial phase breakdown

Trial status

Actively recruiting — 49 trials

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta…

Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized…

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S…

High-Resolution PET-CT Imaging for Surgical Margin Visualization

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

All recent trials (100 shown)

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Full-wrap Versus Conventional Suspension for Reducing Soft Palate Injury Rate

Trial phase breakdown

Trial status

Actively recruiting — 49 trials

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta…

Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized…

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S…

High-Resolution PET-CT Imaging for Surgical Margin Visualization

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

All recent trials (100 shown)

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Full-wrap Versus Conventional Suspension for Reducing Soft Palate Injury Rate

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Trea…

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head a…

The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma

Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients

CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and N…

Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Ea…

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Se…

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive…